Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
China
Peking University， First Hospital, Department of Pediatrics, Beijing Bayi Children's Hospital, Seventh Medical Center, PLA general hospital, Beijing Shengjing Hospital of China Medical University, Shenyang Children's Hospital of Soochow University, Suzhou